Ying Wei Selected Research

VMP regimen

5/2019

Low-risk gestational trophoblastic neoplasia outcome after treatment with VMP regimen from 2005 to 2017.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ying Wei Research Topics

Disease

40	Neoplasms (Cancer) 03/2022 - 01/2003
38	Inflammation (Inflammations) 01/2022 - 01/2011
31	Asthma (Bronchial Asthma) 09/2022 - 07/2010
15	Neoplasm Metastasis (Metastasis) 08/2020 - 01/2003
12	Stroke (Strokes) 01/2022 - 02/2009
11	Infections 05/2022 - 04/2005
11	Respiratory Hypersensitivity 01/2022 - 01/2014
9	Fibrosis (Cirrhosis) 10/2022 - 01/2002
9	Breast Neoplasms (Breast Cancer) 05/2022 - 01/2019
8	Lung Neoplasms (Lung Cancer) 02/2020 - 11/2008
8	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2019 - 01/2011
7	Pneumonia (Pneumonitis) 12/2021 - 01/2014
6	Body Weight (Weight, Body) 01/2022 - 01/2015
6	Insulin Resistance 01/2021 - 01/2017
6	Ischemic Stroke 10/2020 - 09/2010
6	Ischemia 10/2019 - 01/2011
6	Infarction (Infarctions) 03/2015 - 01/2011
5	Necrosis 03/2022 - 01/2015
5	Brain Ischemia (Cerebral Ischemia) 01/2022 - 09/2010
5	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2011
5	Hypoxia (Hypoxemia) 01/2022 - 01/2012
5	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 01/2015
5	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 01/2009
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 11/2011
5	Human Influenza (Influenza) 12/2017 - 07/2015
4	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2013
4	Airway Remodeling 01/2021 - 01/2013
4	Hypertension (High Blood Pressure) 10/2018 - 05/2012
3	Hyperplasia 12/2022 - 06/2015
3	Fatigue 06/2022 - 11/2020
3	Reperfusion Injury 01/2022 - 01/2011
3	COVID-19 12/2021 - 10/2020
3	Sepsis (Septicemia) 11/2021 - 01/2017
3	Atrial Fibrillation 10/2021 - 01/2020
3	Atherosclerosis 01/2021 - 07/2012
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2020 - 10/2009
3	Type 2 Diabetes Mellitus (MODY) 11/2020 - 09/2017
3	Chronic Obstructive Pulmonary Disease (COPD) 09/2020 - 01/2016
3	Myocardial Infarction 02/2020 - 08/2011
3	Adenocarcinoma of Lung 02/2020 - 11/2008
3	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 01/2012
3	Obesity 01/2015 - 05/2013
2	Primary Hyperparathyroidism 09/2022 - 01/2021
2	Hypertrophy 05/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 06/2022 - 10/2009
15	OvalbuminIBA 01/2022 - 01/2015
14	Pharmaceutical PreparationsIBA 03/2022 - 01/2002
11	Biological ProductsIBA 03/2022 - 01/2011
10	CytokinesIBA 09/2022 - 08/2008
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2012
9	CollagenIBA 10/2022 - 10/2017
7	Methacholine Chloride (Methacholine)FDA Link 01/2022 - 01/2014
7	LipidsIBA 01/2022 - 11/2011
7	Interleukin-5 (Interleukin 5)IBA 12/2021 - 01/2014
7	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 12/2011
6	Peptides (Polypeptides)IBA 06/2022 - 11/2008
6	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2014
6	Interleukin-6 (Interleukin 6)IBA 07/2021 - 01/2011
6	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2018
6	Interleukin-4 (Interleukin 4)IBA 12/2020 - 01/2014
6	IntegrinsIBA 01/2014 - 01/2003
5	Eosine Yellowish-(YS) (Eosin)IBA 03/2022 - 02/2013
5	Hematoxylin (Haematoxylon)IBA 03/2022 - 02/2013
5	Long Noncoding RNAIBA 01/2022 - 02/2020
5	LigandsIBA 01/2020 - 11/2008
5	Urokinase Plasminogen Activator ReceptorsIBA 01/2014 - 01/2005
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2022 - 03/2012
4	Therapeutic UsesIBA 01/2022 - 01/2011
4	Messenger RNA (mRNA)IBA 01/2022 - 01/2011
4	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2021 - 11/2011
4	Immunoglobulin E (IgE)IBA 12/2021 - 01/2015
4	Interleukin-13IBA 12/2021 - 04/2019
4	Complement System Proteins (Complement)IBA 01/2021 - 01/2014
4	Transcription Factors (Transcription Factor)IBA 01/2020 - 10/2009
3	Caspase 3 (Caspase-3)IBA 03/2022 - 04/2017
3	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2005
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 04/2017
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2016
3	Interleukin-10 (Interleukin 10)IBA 11/2021 - 12/2020
3	InterleukinsIBA 11/2021 - 10/2018
3	Phosphotransferases (Kinase)IBA 01/2021 - 10/2017
3	GlucocorticoidsIBA 01/2021 - 01/2020
3	SteroidsIBA 01/2021 - 08/2020
3	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 11/2008
3	ChemokinesIBA 01/2020 - 09/2016
3	CalciumIBA 01/2020 - 01/2019
3	Bleomycin (Blenoxane)FDA LinkGeneric 12/2019 - 01/2009
3	salicylhydroxamic acid (SHAM)IBA 10/2019 - 09/2011
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2019 - 08/2008
3	Peroxidase (Myeloperoxidase)IBA 01/2019 - 03/2015
3	EnzymesIBA 01/2019 - 03/2015
3	SmokeIBA 01/2018 - 07/2015
3	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2008 - 01/2005
2	Immunoglobulin G (IgG)IBA 12/2022 - 04/2019

Therapy/Procedure

23	Therapeutics 09/2022 - 08/2008
9	Drug Therapy (Chemotherapy) 01/2022 - 08/2008
5	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2021 - 01/2014
4	Acupuncture Therapy 02/2021 - 01/2015
3	Chemoradiotherapy 12/2020 - 01/2013
2	Parathyroidectomy 09/2022 - 01/2020